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Introduction
Calprotectin (S100A8/A9) is an example of a damage asso-
ciated molecular pattern and a TLR4 ligand. It is expressed
in neutrophils, monocytes and early infiltrating macro-
phages. Calprotectin, once secreted, has a number of pro-
inflammatory effects on activated endothelium and on
phagocytes and reflects activation of the innate immune
system. Calprotectin has been demonstrated to be secreted
during inflammation and play a role in a number of
inflammatory diseases. In view of calprotectin reflecting
monocyte activation, we aimed to investigate calprotectin
in patients with Familial Mediterranean Fever (FMF).
Patients and methods
All patients were genotyped with detailed well charac-
terised mutations. Serial levels of serum of calprotectin
were measured by ELISA. Patients and healthy controls
(HC) cell surface calprotectin on monocytes and neutro-
phils as well as intracellular peripheral blood mononuclear
cells (PBMC) calprotectin expression were measured by
flow cytometry (FACS). CD14 cells were isolated and fol-
lowing overnight incubation with or without LPS, calpro-
tectin was measured in the supernatants by ELISA. Patient
and HC CD14 cells apoptosis was compared.
Results
Patients with FMF have greatly elevated levels of calpro-
tectin. Median levels (range) in homozygous patients
(n=87) 9039 ng/ml (500-33544 ng/ml), heterozygous with
symptoms (n=81) median 9062 ng/ml (1744-38119 ng/
ml), heterozygous without symptoms (n=56) 9736 ng/ml
(5205-19205), homozygous/compound without FMF
(n=16) 34033 ng/ml (range 2547-40000 ng/ml). All groups
were significantly greater than HCs (n=15)(p<0.001).
There was no difference between the different mutations.
Patients on anakinra (n=4) had persistently high levels
despite controlled disease. There was a correlation
between cell surface expression of calprotectin on mono-
cytes and neutrophils (n=22) with CRP (r=0.62). Following
stimulation of CD14 cells overnight with LPS, there was
significantly more calprotectin detected in the superna-
tants in patients (n=7) than healthy control CD14 cells
(n=3)(patients median 157.9ng/ml [range 90.8-313.4], HC
median 90.62ng/ml [range 76.0-122.3]) (p<0.05 Mann
Whitney U-test). There was a trend to an increased mean
florescent intensity (MFI) in intracellular monocyte cal-
protectin following PBMC isolation (patients n=8, HC
n=4), but this didn’t reach significance.
Conclusion
Patients with homozygous mutations both with and without
disease have elevated serum calprotectin which doesn’t
correspond to disease activity unlike some autoimmune dis-
eases. Cell surface expression on monocytes and neutrophils
is low and correlates with the CRP response. The results
suggest a trend to increased intracellular calprotectin
expression, and more secretion by CD14 cells following sti-
mulation with LPS. Lastly, apoptosis of monocytes is similar
between patients and HC, suggesting that increased apopto-
sis does not have a role in the high serum levels observed.
The exact mechanism by which these patients, especially
those with mutations but no clinical disease, demonstrate
elevated serum calprotectin remains to be elucidated.
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